Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia

20260 citationsJournal Articlediamond Open Access

Authors

Cardioform appears more cost-effective in the prevention of secondary PFO-associated strokes, supporting its adoption in clinical practice.

Published in: Journal of Medical Economics

Volume 29, Issue 1, pp. 363-379

Field-Weighted Citation Impact: 0.00